DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Friday after StockNews.com downgraded the stock from a buy rating to a hold rating. The company traded as low as $17.09 and last traded at $17.15, with a volume of 6160723 shares trading hands. The stock had previously closed at $18.81.
Several other research analysts have also issued reports on XRAY. UBS Group dropped their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Mizuho initiated coverage on DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price objective on the stock. Leerink Partners downgraded DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research report on Thursday, November 7th. Leerink Partnrs cut shares of DENTSPLY SIRONA from a "strong-buy" rating to a "hold" rating in a report on Thursday, November 7th. Finally, Wells Fargo & Company decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a report on Friday. Eleven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $23.58.
Read Our Latest Stock Analysis on DENTSPLY SIRONA
Insiders Place Their Bets
In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.52% of the stock is owned by company insiders.
Institutional Trading of DENTSPLY SIRONA
A number of hedge funds have recently bought and sold shares of XRAY. Pacer Advisors Inc. lifted its holdings in shares of DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock valued at $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Nuance Investments LLC lifted its holdings in shares of DENTSPLY SIRONA by 25.0% during the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Norges Bank purchased a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $45,730,000. AQR Capital Management LLC lifted its holdings in shares of DENTSPLY SIRONA by 245.1% during the 4th quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier's stock valued at $54,389,000 after purchasing an additional 2,054,767 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its holdings in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after purchasing an additional 1,975,404 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.
DENTSPLY SIRONA Stock Performance
The firm has a fifty day moving average price of $18.77 and a 200 day moving average price of $21.39. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The stock has a market cap of $3.10 billion, a PE ratio of -7.53, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.
DENTSPLY SIRONA Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. The ex-dividend date is Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.11%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.
DENTSPLY SIRONA Company Profile
(
Get Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Recommended Stories
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
